Institutional investors purchased a net $170.2 thousand shares of CVM during the quarter ended March 2017, and now own 7.60% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CORNERSTONE FINANCIAL PARTNERS L... Sold 527.00 shares of CEL-SCI Corp